Articles & Video
Innovating CMC for Oligonucleotide and Peptide Therapeutics
In a new ebook, we look at ways to optimize chemistry manufacturing and controls for oligonucleotide and peptide therapeutics.
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Strategies to Innovate the Production of Next Generation Bioconjugates
From developing ADCs to tumor-targeting, this whitepaper reviews the latest common challenges and novel strategies for producing bioconjugates.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Partnering in the oligonucleotide and peptide therapeutics industry - WHITEPAPER
This whitepaper looks at the partnering challenges and opportunities facing the peptide and oligonucleotide therapeutics industry, using a number of case studies.
Manufacturing oligonucleotides: addressing safety and delivery challenges
We explore ways to tackle the main challenges in designing control strategies for oligonucleotide therapeutics.
Regulatory challenges and strategies for oligonucleotide, peptide and mRNA therapeutics - WHITEPAPER
We explore the regulatory challenges and successful approval strategies for oligonucleotide, peptide and mRNA therapeutics.
What is an oligonucleotide?
What is an oligonucleotide? Discover the different oligo classes and the future of oligonucleotide therapies.
Drug delivery trends in oligo, peptide, mRNA and CRISPR therapeutics
What are the current strategies and technology demands in delivering oligos, peptides mRNA and CRISPR therapeutics? We find out from our recent survey data.
What are peptides?
What are peptides? We look at the potential of the peptide in the beauty industry and in peptide therapeutics.
How oligonucleotide, peptide, CRISPR and mRNA companies are using collaboration to move forward
We examined recent survey data to explore how collaboration is used by oligonucleotide, peptide, CRISPR and mRNA companies throughout their supply chains.
The future of peptide vaccines and personalized peptide therapies - WHITEPAPER
This whitepaper explores the exciting potential future of peptide vaccines and personalized peptide therapies.
REPORT: State of Oligo, Peptide, mRNA and CRISPR Therapeutics 2019
This exclusive report explores the state of the oligo, peptide, mRNA and CRISPR therapeutics industry in 2019 - download it here.
CMC approaches to accelerate peptide, oligonucleotides and mRNA therapeutics development - WHITEPAPER
This whitepaper explores the different CMC approaches to accelerate peptide, oligonucleotides and mRNA therapeutics development. Download it here.
Boosting commercialization of oligonucleotides as a raw materials supplier with Aldevron
Tom Lynch, Vice President of Sales & Client Development at Aldevron joined us at TIDES US in San Diego to discuss the company's role as a CDMO and how it is approaching the oligonucleotides market as a critical raw materials supplier.